Rapid Detection of Influenza A Pandemic (H1N1) 2009 Virus Neuraminidase Resistance Mutation H275Y by Real-Time Reverse Transcriptase PCR

ABSTRACT The emergence of oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus highlights the need for rapid oseltamivir resistance screening. We report the development and validation of high-throughput real-time reverse transcriptase PCR assays for the detection of the H275Y substitution in the neuraminidase 1 gene that can be accomplished in 3 to 4 h.

[1]  Update : Drug Susceptibility of Swine-Origin Influenza A ( H 1 N 1 ) Viruses , 2022 .

[2]  I. Barr,et al.  Oseltamivir Resistance and the H274Y Neuraminidase Mutation in Seasonal, Pandemic and Highly Pathogenic Influenza Viruses , 2012, Drugs.

[3]  G. Sabatinelli,et al.  Characterization of Large Mumps Outbreak among Vaccinated Palestinian Refugees , 2009, Journal of Clinical Microbiology.

[4]  S. Günther,et al.  Detection of influenza A(H1N1)v virus by real-time RT-PCR. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[5]  A. Amonsin,et al.  H5N1 Oseltamivir-resistance detection by real-time PCR using two high sensitivity labeled TaqMan probes , 2006, Journal of Virological Methods.

[6]  Hideo Goto,et al.  Avian flu: Isolation of drug-resistant H5N1 virus , 2005, Nature.

[7]  R. Webster,et al.  Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay. , 2002, Antiviral research.

[8]  A. Osterhaus,et al.  Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase , 2009, Journal of Clinical Virology.

[9]  Thanyada Rungrotmongkol,et al.  Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus. , 2009, Biochemical and biophysical research communications.

[10]  Oseltamivir-resistant pandemic (H1N1) 2009 influenza virus, October 2009. , 2009, Releve epidemiologique hebdomadaire.

[11]  M. Zambon,et al.  Influenza antiviral susceptibility monitoring activities in relation to national antiviral stockpiles in Europe during the winter 2006/2007 season. , 2007, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[12]  R. Garten,et al.  Detection of Molecular Markers of Drug Resistance in 2009 Pandemic Influenza A (H1N1) Viruses by Pyrosequencing , 2009, Antimicrobial Agents and Chemotherapy.

[13]  Sarah Palmer,et al.  Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy , 2006, AIDS.

[14]  Tanja Popovic,et al.  Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009. , 2009, MMWR. Morbidity and mortality weekly report.

[15]  L. Gubareva,et al.  Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors. , 2004, Virus research.

[16]  T. Mazzulli,et al.  Development of a novel real-time reverse-transcriptase PCR method for the detection of H275Y positive influenza A H1N1 isolates , 2009, Journal of Virological Methods.

[17]  J. McKimm-Breschkin,et al.  Resistance of influenza viruses to neuraminidase inhibitors--a review. , 2000, Antiviral research.